For Immediate Release
New Group Promotes Artificial Intelligence, Robotics, Automation in Healthcare
Washington, DC – Antiquated approaches and resistance to change hampers patient access to quality care and inflates costs according to a new organization promoting the use of artificial intelligence and related technologies in healthcare. The Partnership for Artificial Intelligence and Automation in Healthcare (PATH) unites health systems, industry, payers and regulators to find how such technology can improve the delivery of medicine, reduce costs and expand access to healthcare services to millions of people across the globe.
The mission-driven, membership-based group takes a unique, inclusive approach bringing together all stakeholders to resolve such issues as public policy oversight, personal safety and how to integrate such revolutionary advances into healthcare systems. Information about PATH and its inaugural summit is available at www.pathhealth.com and www.pathhealth.org.
Established by two widely-known and well-respected leaders in healthcare and technology, PATH has also named a distinguished Board of Advisors.
|
“AI and related innovations have already enabled industries such as banking, aviation, and entertainment to grow, provide higher- quality products, and allow consumers greater choice,” stated Jonathan Linkous, a co-founder and CEO of the group. “With spiraling costs, increasing need, decreasing resources, and rapidly advancing technologies, healthcare desperately needs to catch up.” Linkous was the founding CEO of the American Telemedicine Association and led the development of telemedicine from concept to reality for the past 24 years, making it a well- known and accepted technology, improving outcomes, creating a growing market, and overcoming barriers. |
|
|
Mary Ann Liebert, PATH’s co-founder, is the president, and CEO of Mary Ann Liebert, Inc., one of the world’s best known and most respected publishers of scientific and medical books, journals, and digital information in fields such as telemedicine, health transformation, big data, and CRISPR. “I am excited about the formation of PATH and look forward to combining forces to help bring these lifesaving technologies to patients in need.” |
PATH's initial Advisory Board includes:
|
Stephen Klasko, MD, MBA, |
Jay H. Sanders, MD, |
Sue Siegel, |
Rick Valencia, |
Yulun Wang, |